All Episodes

October 30, 2025 โ€ข 4 mins

๐Ÿง  TACSI Trial in NEJM (Sep 2025) challenges the status quo on dual antiplatelet therapy after CABG for ACS!

๐Ÿ‘จโ€โš•๏ธ 2201 patients across 5 Nordic countries

๐Ÿ’Š Ticagrelor + Aspirin โ‰  better outcomes vs Aspirin alone

๐Ÿ“‰ No reduction in death, MI, stroke, or revascularization

๐Ÿฉธ But bleeding (4.9% vs 2.0%) & dyspnea (18.2% vs 6.4%) increased

๐Ÿ“š Guidelines may need rethinking.

ย 

๐Ÿ“– Jeppsson A et al. N Engl J Med. 2025; DOI: 10.1056/NEJMoa2508026

#TACSI #Cardiology #CABG #DAPT #ACS #NEJM #PrecisionMedicine #RCT #BleedingRisk #ClinicalTrials

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

On Purpose with Jay Shetty

On Purpose with Jay Shetty

Iโ€™m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and Iโ€™m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood youโ€™re able to deal with relationship struggles, work challenges and lifeโ€™s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them weโ€™ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I donโ€™t take it for granted โ€” click the follow button and leave a review to help us spread the love with On Purpose. I canโ€™t wait for you to listen to your first or 500th episode!

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

ยฉ 2025 iHeartMedia, Inc.